DrugPatentWatch Database Preview
Profile for Japan Patent: H05505794
US Patent Family Members and Approved Drugs for Japan Patent: H05505794
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Mar 9, 2021 | Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate |
➤ Sign Up | Nov 4, 2020 | Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate |
➤ Sign Up | Sep 9, 2021 | Gilead | EMTRIVA | emtricitabine |
➤ Sign Up | Sep 9, 2021 | Gilead Sciences | ATRIPLA | efavirenz; emtricitabine; tenofovir disoproxil fumarate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |